VIROCHEM PHARMA
ViroChem Pharma is a privately held company with two investigational HCV polymerase inhibitors in clinical development.
Current Advisors List
Investors List
BDC Venture Capital
BDC Venture Capital investment in Venture Round - ViroChem Pharma
Official Site Inspections
http://www.virochempharma.com
Unable to get host informations!!!
More informations about "ViroChem Pharma"
ViroChem Pharma - Crunchbase Company Profile & Funding
ViroChem Pharma is a privately held company with two investigational HCV polymerase inhibitors in clinical development.See details»
Organization | ViroChem Pharma
ViroChem Pharma Report issue. For profit Phase 1 Phase 2. Founded: Laval Canada ... Organization Overview. First Clinical Trial. 2006 NCT00389298. First Marketed Drug. None …See details»
ViroChem Pharma - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for ViroChem Pharma. Use the PitchBook Platform to explore the full profile.See details»
ViroChem Pharma Inc - LinkedIn
العربية (Arabic) ÄŒeÅ¡tina (Czech) Dansk (Danish) Deutsch (German) English (English) Español (Spanish)See details»
Vertex Pharmaceuticals acquires ViroChem Pharma - 2009-03-12 ...
Mar 12, 2009 · ViroChem Pharma ViroChem Pharma is a privately held company with two investigational HCV polymerase inhibitors in clinical development. Acquiring Organization: …See details»
ViroChem Pharma - Ownership and Business Overview - Mergr
Mar 12, 2009 · ViroChem Pharma is headquartered in Laval, Quebec. What sector is ViroChem Pharma in? ViroChem Pharma is a life science company. When was ViroChem Pharma …See details»
ViroChem Pharma - Funding, Financials, Valuation & Investors
ViroChem Pharma is a privately held company with two investigational HCV polymerase inhibitors in clinical development.See details»
Organization | ViroChem Pharma - CDEK
ViroChem Pharma Report issue. For profit Phase 1 Phase 2. Founded: Laval Canada (2004) Status: Acquired by Vertex (2009 ...See details»
ViroChem Pharma | BDC.ca
ViroChem Pharma Inc. is a privately held company with two investigational HCV polymerase inhibitors in clinical development. Vertex Pharmaceuticals acquired ViroChem.See details»
Vertex Acquires Virochem Pharma - Chemical & Engineering News
Mar 9, 2009 · Vertex Pharmaceuticals has agreed to pay roughly $375 million in cash and stock for ViroChem Pharma, a privately held, Montreal-based biotech firm founded in 2004 with …See details»
ViroChem Pharma Inc - Company Profile and News - Bloomberg …
Company profile page for ViroChem Pharma Inc including stock price, company news, executives, board members, and contact informationSee details»
ViroChem Pharma - Products, Competitors, Financials, Employees ...
Jul 31, 2013 · What is ViroChem Pharma's latest funding round? ViroChem Pharma's latest funding round is Acquired. Who are the investors of ViroChem Pharma? Investors of …See details»
Vertex completes acquisition of ViroChem Pharma
Vertex now owns worldwide rights to the ViroChem HCV drug development portfolio, including VCH-222 and VCH-759, which have demonstrated substantial reductions in plasma HCV RNA …See details»
Vertex buys ViroChem in $375M in hep C deal | Fierce Biotech
Mar 4, 2009 · With its closely-watched hep C drug telaprevir working its way toward an FDA filing, Vertex Pharmaceuticals announced that it is buying Canada's ViroChem Pharma for $375 …See details»
ViroChem Pharma Stock Price, Funding, Valuation, Revenue
See ViroChem Pharma funding rounds, investors, investments, exits and more. Evaluate their financials based on ViroChem Pharma's post-money valuation and revenue.See details»
ViroChem Pharma completes US$400 million sale to Vertex …
ViroChem Pharma, based in Laval, Québec, engages in researching, developing, and producing drugs for viral diseases. It offers drugs for HCV and HIV infections. Vertex Pharmaceuticals, …See details»
ViroChem Pharma | BDC.ca
ViroChem Pharma inc. est une société fermée ayant deux inhibiteurs expérimentaux de la polymérase du VHC au stade du développement clinique.See details»
ViroChem Pharma - Contacts, Employees, Board Members
ViroChem Pharma is a privately held company with two investigational HCV polymerase inhibitors in clinical development.See details»
BDC Venture Capital, Caisse de dépôt et placement du Québec …
ViroChem Pharma, a spinoff of Biochem Pharma, in which the Fund invested some $12 million over the years, also generated excellent returns for the company. The Fund believes in this …See details»
ViroChem Pharma - CB Insights
ViroChem Pharma has 4 executives. ViroChem Pharma's current Chief Executive Officer is Gervais Dionne. You're one click away from the most comprehensive, unmatched analyst …See details»